Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Evidence from a Real-World Perspective - Part 2
- 20 June 2019
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 26 (10) , 1734-1745
Abstract
BACKGROUND: We report a comprehensive overview of current COPD therapies from a real-world experience. OBJECTIVE: Critically review the opportunities and the challenges occurring in the real-world treatment of COPD. METHODS: This is a review that also reports data to evaluate COPD patient’ response to standardized therapy in a real-world setting. CONCLUSION: Comprehensive assessment of COPD management requires strategies able to evaluate efficacy and usefulness in a real-world population, that take into account the interaction between experience and academic training, research, adherence to guidelines and judgments in order to plan the appropriate and optimum use of available strategies.Keywords
This publication has 25 references indexed in Scilit:
- Efficacy versus effectiveness trialsCurrent Opinion in Allergy and Clinical Immunology, 2013
- Predicting Outcomes from 6-Minute Walk Distance in Chronic Obstructive Pulmonary DiseaseJournal of the American Medical Directors Association, 2012
- Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary diseaseBritish Journal of Pharmacology, 2011
- Six-Minute Walk Distance in Patients With Severe End-Stage COPDJournal of Cardiopulmonary Rehabilitation and Prevention, 2010
- Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trialsThe Lancet, 2009
- Inhaled corticosteroids in COPD: a case in favourEuropean Respiratory Journal, 2009
- Inhaled corticosteroids in COPD: the case against: Fig. 1—European Respiratory Journal, 2009
- Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint CommitteeThorax, 2007
- Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung diseaseLife Sciences, 1999
- A Randomized, Controlled Trial of Theophylline in Patients with Severe Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1989